Further novel forms of interfering RNA molecules

Details for Australian Patent Application No. 2012216354 (hide)

Owner Silence Therapeutics AG

Inventors Giese, Klaus; Kaufmann, Jorg; Klippel-Giese, Anke

Agent Pizzeys

Pub. Number AU-A-2012216354

Parent 2008207337

Filing date 22 August 2012

Wipo publication date 13 September 2012

International Classifications

C12N 15/11 Mutation or genetic engineering - DNA or RNA fragments

A01K 67/027 Rearing or breeding animals, not otherwise provided for - New breeds of vertebrates

A61K 31/713 - Double-stranded nucleic acids or oligonucleotides

C07H 21/00 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12N 5/10 Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12Q 1/68 Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

A61K 38/00 Medicinal preparations containing peptides

Event Publications

6 September 2012 Complete Application Filed

13 September 2012 Application Open to Public Inspection

  Published as AU-A-2012216354

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012216355-Automated Price Improvement Protocol Processor

2012216353-Barista gripp